Clinical Report: Visualization of Knowledge Graphs in Pediatric Cardiomyopathy

Overview

This study systematically reviews global research on pediatric cardiomyopathy genetics from 2000 to 2024, revealing key themes and trends. It highlights the integration of genetic research into digital healthcare, emphasizing precision medicine and multi-omics approaches.

Background

Pediatric cardiomyopathy is a significant cause of heart failure and sudden cardiac death in children, necessitating improved genetic understanding for better management. The evolution of genetic testing technologies has transformed the diagnosis and treatment landscape, making it crucial for pediatric healthcare. Addressing this public health challenge requires a comprehensive understanding of the genetic underpinnings and their clinical implications.

Data Highlights

Key Findings

• Research on pediatric cardiomyopathy genetics has grown from 2000 to 2024, with 1,438 articles published.
• The United States, China, and the United Kingdom are the leading contributors to this research.
• Five core themes were identified, including disease classification and therapeutic mechanisms.
• Research evolution has progressed through three phases: single-gene screening, multi-omics integration, and precision medicine.
• Integration of multi-omics data and AI is enhancing personalized risk assessment and monitoring.

Clinical Implications

Healthcare professionals should prioritize genetic testing and counseling in pediatric cardiomyopathy management. The findings underscore the importance of integrating advanced genetic insights into clinical practice to improve patient outcomes and guide treatment strategies.

Conclusion

The study illustrates the rapid advancement of genetic research in pediatric cardiomyopathy, emphasizing the shift towards precision medicine and the integration of digital healthcare solutions. Continued exploration in this field is essential for enhancing pediatric cardiovascular health management.

Related Resources & Content

1. Pediatric Cardiology, Springer, 2024 -- Resources for Genetic Testing and Clinical Approaches in Pediatric Cardiomyopathy Programs
2. European Journal of Preventive Cardiology, 2024 -- Impact of Parental Hypertension, Diabetes, and Dyslipidemia on Cardiac Health in Offspring
3. npj Digital Medicine, 2026 -- Empowering genetic discoveries and cardiovascular risk assessment by predicting electrocardiograms from genotype
4. Integration of genetic testing into diagnostic pathways for cardiomyopathies, PubMed, 2023 -- Clinical consensus statement by the ESC Council on Cardiovascular Genomics
5. npj Digital Medicine — xGNN4MI: Enhancing Interpretability of Graph Neural Networks in 12-Lead ECG for Cardiovascular Disease Assessment
6. ESC Guidelines on Cardiomyopathy
7. AHA Scientific Statement on Genetic Testing for Heritable Cardiovascular Diseases
8. Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics - PubMed
9. Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy | New England Journal of Medicine
10. Mavacamten Improves Obstruction in Adolescents with HCM - American College of Cardiology
11. Study Details | NCT06412666 | A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). | ClinicalTrials.gov
12. First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1 - PubMed
13. Genomics of pediatric cardiomyopathy | Pediatric Research
14. A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseases - ScienceDirect
15. Yield on Reinterpretation of Genetic Variants in Pediatric Cardiomyopathy - PMC
16. The yield on re-interpretation of genetic variants in pediatric cardiomyopathy